IL87778A - Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparation - Google Patents

Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparation

Info

Publication number
IL87778A
IL87778A IL87778A IL8777888A IL87778A IL 87778 A IL87778 A IL 87778A IL 87778 A IL87778 A IL 87778A IL 8777888 A IL8777888 A IL 8777888A IL 87778 A IL87778 A IL 87778A
Authority
IL
Israel
Prior art keywords
therapeutically active
preparation
pharmaceutical compositions
active proteins
topical pharmaceutical
Prior art date
Application number
IL87778A
Other languages
English (en)
Other versions
IL87778A0 (en
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL87778A0 publication Critical patent/IL87778A0/xx
Publication of IL87778A publication Critical patent/IL87778A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
IL87778A 1987-09-17 1988-09-16 Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparation IL87778A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873731255 DE3731255A1 (de) 1987-09-17 1987-09-17 Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen

Publications (2)

Publication Number Publication Date
IL87778A0 IL87778A0 (en) 1989-03-31
IL87778A true IL87778A (en) 1993-05-13

Family

ID=6336244

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87778A IL87778A (en) 1987-09-17 1988-09-16 Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparation

Country Status (20)

Country Link
EP (1) EP0307857B1 (fr)
JP (1) JP2783552B2 (fr)
KR (1) KR970008112B1 (fr)
AT (1) ATE126063T1 (fr)
AU (1) AU615473B2 (fr)
CA (1) CA1329121C (fr)
DD (1) DD274562A5 (fr)
DE (2) DE3731255A1 (fr)
DK (1) DK516288A (fr)
ES (1) ES2077559T3 (fr)
FI (1) FI95770C (fr)
GR (1) GR3017432T3 (fr)
HU (1) HU203045B (fr)
IE (1) IE70908B1 (fr)
IL (1) IL87778A (fr)
NO (1) NO179436C (fr)
NZ (1) NZ226209A (fr)
PT (1) PT88539B (fr)
RU (1) RU2093145C1 (fr)
ZA (1) ZA886903B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
RU2132184C1 (ru) * 1998-12-16 1999-06-27 Краснодарская научно-исследовательская ветеринарная станция Способ получения препарата "жироформ-плюс" для лечения и профилактики эндометритов у коров
DK2153819T3 (da) * 2000-07-14 2012-12-03 Allergan Inc Anvendelse af en opløselighedsforbedrende bestanddel i en vandig sammensætning omfattende brimonidintartrat
RU2216313C2 (ru) * 2000-12-25 2003-11-20 Савченков Сергей Николаевич Лечебно-профилактическое косметическое средство
RU2188665C1 (ru) * 2001-04-09 2002-09-10 Щербакова Элеонора Григорьевна Противовирусное и антибактериальное средство "интерлизин"
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
US9555120B2 (en) 2010-05-04 2017-01-31 Viscogel Ab Chitosan composition
RU2431489C1 (ru) * 2010-05-25 2011-10-20 Федеральное государственное учреждение "Российский научный центр рентгенорадиологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "РНЦРР Росмедтехнологий") Способ лечения хронических воспалительных заболеваний толстого кишечника
KR20260035292A (ko) * 2017-06-12 2026-03-12 레이크우드 아메덱스, 인크. 비스포스포신 겔 제제 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5413223A (en) * 1977-07-01 1979-01-31 Ricoh Co Ltd Printer unit
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
CA1190148A (fr) * 1981-10-13 1985-07-09 Samuel S. Asculai Composes contenant de l'interferon
JPS5892622A (ja) * 1981-11-28 1983-06-02 Sunstar Inc インタ−フエロン安定配合製剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5910524A (ja) * 1982-07-08 1984-01-20 Toray Ind Inc インタ−フエロン組成物およびその製造法
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
EP0177342A3 (fr) * 1984-10-04 1987-12-02 Genentech, Inc. Formulations orales de protéines thérapeutiques
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like

Also Published As

Publication number Publication date
KR970008112B1 (ko) 1997-05-21
NO179436C (no) 1996-10-09
ZA886903B (en) 1990-05-30
FI884240L (fi) 1989-03-18
IE70908B1 (en) 1997-01-15
FI884240A0 (fi) 1988-09-15
KR890004719A (ko) 1989-05-09
PT88539A (pt) 1988-10-01
DE3731255A1 (de) 1989-04-06
PT88539B (pt) 1992-11-30
NO884123L (no) 1989-03-20
NO179436B (no) 1996-07-01
CA1329121C (fr) 1994-05-03
DE3854290D1 (de) 1995-09-14
JP2783552B2 (ja) 1998-08-06
EP0307857A1 (fr) 1989-03-22
ES2077559T3 (es) 1995-12-01
HU203045B (en) 1991-05-28
AU615473B2 (en) 1991-10-03
IE882812L (en) 1989-03-17
ATE126063T1 (de) 1995-08-15
GR3017432T3 (en) 1995-12-31
IL87778A0 (en) 1989-03-31
JPH01102029A (ja) 1989-04-19
FI95770B (fi) 1995-12-15
AU2231688A (en) 1989-03-23
DK516288D0 (da) 1988-09-16
DK516288A (da) 1989-03-18
NO884123D0 (no) 1988-09-16
DD274562A5 (de) 1989-12-27
NZ226209A (en) 1991-06-25
EP0307857B1 (fr) 1995-08-09
RU2093145C1 (ru) 1997-10-20
HUT47436A (en) 1989-03-28
FI95770C (fi) 1996-03-25

Similar Documents

Publication Publication Date Title
EP0275005A3 (en) Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them
ZA896287B (en) Pharmaceutical combination preparations for use in anti-neoplastic therapy
ZA885192B (en) Pharmaceutical preparations
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
CA2005143A1 (fr) Formule proteique hydrophobe stabilise de g-csf
IL87778A (en) Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparation
WO1987003480A3 (fr) Medicament a effet anti-tumoral contenant de l'hexadecylphosphocholine
AU1099288A (en) Drug delivery system and method of making the same
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
PT97160A (pt) Processo para a preparacao de composicoes estaveis para administracao parenterica contendo uma proteina, peptideo ou polipeptideo biologicamente activo
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
PT996462E (pt) Preparados de combinacoes farmaceuticas contendo eritropoietina e hemoglobinas modificadas
AU563762B2 (en) S-adenosyl-l-methionine salts preparation
CY1858A (en) Pharmaceutical preparation for the systemic treatment of toy fish and domestic fish
AU1518492A (en) Pharmaceutical compositions for transcutaneous administration
AU586988B2 (en) Solid drug formulations and stable suspensions
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
EP0351876A3 (fr) Composition pour augmenter l'effet de vaccination
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
GR3032639T3 (en) Vehicles for oral adminstration of pharmaceutically active acide labile substances.
IL81926A0 (en) Pharmaceutical compositions for the oral administration of active proteins

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXTN Extension order renewed